Can you "inject marijuanas," as the satirical memes suggest? Yes, but it’s a really, really stupid thing to do, according to a new study. Marijuana addiction specialist Dr. Christian Thurstone conjured images like the one seen here when, earlier this week, he shared what he sees as evidence of weed users searching for bigger and bigger highs — and added his fear that such people may soon turn to injecting THC, the active ingredient… Cannabis is widely used recreationally and for symptomatic relief in a number of ailments. However, cannabis has been implicated as a risk factor for the development of psychotic illness. For forty years researchers have utilised intravenous preparations of Δ(9)-THC, as well as several other phytoca …
Can You Inject CBD Oil
Can you “inject marijuanas,” as the satirical memes suggest? Yes, but it’s a really, really stupid thing to do, according to a new study.
A new study found that injecting pure THC triggered schizophrenia-like behaviors in subjects. But, uh, does anyone actually consume weed this way?
The study, conducted by schizophrenia researchers at the Veterans Affairs Healthcare System in Connecticut, and recently published in Neuropsychopharmacology, involved shooting up 22 healthy individuals with 2.5mg THC, 5mg THC, or a placebo (0mg THC). The subjects had previously been “exposed” to cannabis, but none had been diagnosed with cannabis use disorder.
After three separate days of mainlining pure THC, the subjects reported experiencing schizophrenia-like symptoms, increased anxiety, altered perceptions, euphoria, and a host of memory and speech issues. Their blood also showed increased levels of cortisol, the primary stress hormone. Not surprisingly, the researchers concluded that THC produces psychotic behaviors, and more studies are needed to see how cannabinoid receptors may contribute to psychotic disorders.
Usually when we see anything about injecting THC or “marijuanas,” it comes from satirical social media accounts that claim shooting up weed can cause everything from suddenly turning someone gay to spontaneous death (again, these are memes). But intravenous administration of THC is a standard (though not terribly common) practice in cannabis studies, since it gives researchers precise control over dosing. The only problem with this study and others like it is that no one actually injects pure THC. There’s a reason why most consumers prefer to smoke or vape cannabis, after all.
When someone smokes, let’s say, a one-gram joint rolled with weed containing 25 percent THC, that joint contains, roughly, 250mg of THCA, the form of THC that doesn’t get anyone high. Heat converts some THCA into THC — the stuff that gets people lit — but only some THCA turns into the psychoactive form. The average time that heat is applied to the joint isn’t long enough to convert all of the THCA to THC. Furthermore, a bunch of converted THC gets lost in the smoke that wafts from the joint, and even more THC gets stuck in the ash.
So, by the end of it, even if just one person smoked that entire 1-gram joint to the face, they’re only getting a small fraction of that potential 250mg THC, not to mention a cornucopia of other compounds such as other cannabinoids, terpenes, flavonoids, and polyphenols — which all may interact with our brain’s cannabinoid receptors, dulling the negative effects of THC.
In other words, shooting someone up with 2.5mg or 5mg pure THC is kind of a lot, especially for non-stoners, which this study focused on.
In addition to there being next-to-no people who shoot up THC distillate or diamonds on a regular basis, no one shoots up actual weed, either. Back in the ‘70s and ‘80s, some idiots tried that, and they developed what’s called “intravenously injected marijuana disorder.” Basically, folks would boil weed buds into a “broth,” pull that filtered broth up into a syringe, then inject it. Rather than getting lit, they got sick AF instead, which included bouts of vomiting, intense muscle pains, and serious heart problems.
Here’s the thing about IV marijuana disorder, too: There are practically no new case studies on it after 1986, suggesting that only a handful of people did it back in the day. Why? Obviously, it sucks, and it’s potentially life-threatening. Which is why, today and in the past, folks have stuck to puffing their pot.
Does this mean that everything about the VA study is bogus? Not entirely. We know that the endocannabinoid system plays a role in some mental disorders, and cannabis use can aggravate some psychotic symptoms in people particularly prone to them. However, many cannabis patients consume weed to alleviate symptoms of their personality or mood disorders, too, so the issue isn’t black-and-white, nor is it clear-cut.
Oh, and in case if you’re wondering if you can snort weed, yeah, technically, that’s possible. But you’ll end up blowing pot-snot all day and never catching a buzz.
Marijuana: THC-injection fears are “idiotic,” says doctor and cannabis expert
Marijuana addiction specialist Dr. Christian Thurstone conjured images like the one seen here when, earlier this week, he shared what he sees as evidence of weed users searching for bigger and bigger highs — and added his fear that such people may soon turn to injecting THC, the active ingredient in pot.
Dr. Bob Melamede, among the country’s most vocal advocates for the medicinal benefits of cannabis, pulls no punches when asked his opinion about such a prospect. “This is nonsense,” he says. “It’s idiotic.”
KEEP WESTWORD FREE. Since we started Westword, it has been defined as the free, independent voice of Denver, and we’d like to keep it that way. With local media under siege, it’s more important than ever for us to rally support behind funding our local journalism. You can help by participating in our “I Support” program, allowing us to keep offering readers access to our incisive coverage of local news, food and culture with no paywalls.
Michael Roberts has written for Westword since October 1990, serving stints as music editor and media columnist. He currently covers everything from breaking news and politics to sports and stories that defy categorization.
Cannabis in the arm: what can we learn from intravenous cannabinoid studies?
Cannabis is widely used recreationally and for symptomatic relief in a number of ailments. However, cannabis has been implicated as a risk factor for the development of psychotic illness. For forty years researchers have utilised intravenous preparations of Δ(9)-THC, as well as several other phytocannabinoids, in a laboratory setting. The intravenous route has the most reliable pharmacokinetics, reducing inter-individual variation in bioavailability and is well suited for the delivery of synthetic compounds containing a sole pharmacological moiety. Given the association between cannabinoids and psychotic illness, there has been a resurgence of interest in experimental studies of cannabinoids in humans, and the intravenous route has been employed. Here in a critical review, we appraise the major findings from recent intravenous cannabinoid studies in humans and trace the historical roots of this work back to the 1970’s.
Manwell LA, Ford B, Matthews BA, Heipel H, Mallet PE. Manwell LA, et al. J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):112-9. doi: 10.1016/j.vascn.2014.06.004. Epub 2014 Jun 21. J Pharmacol Toxicol Methods. 2014. PMID: 24956154
Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, Huestis MA. Milman G, et al. Ther Drug Monit. 2014 Apr;36(2):218-24. doi: 10.1097/FTD.0b013e3182a5c446. Ther Drug Monit. 2014. PMID: 24067260 Free PMC article. Clinical Trial.
Manwell LA, Charchoglyan A, Brewer D, Matthews BA, Heipel H, Mallet PE. Manwell LA, et al. J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):120-7. doi: 10.1016/j.vascn.2014.06.006. Epub 2014 Jun 25. J Pharmacol Toxicol Methods. 2014. PMID: 24973534
Goullé JP, Guerbet M. Goullé JP, et al. Bull Acad Natl Med. 2014 Mar;198(3):541-56; discussion 556-7. Bull Acad Natl Med. 2014. PMID: 26427296 Review. French.
Khiabani HZ, Mørland J. Khiabani HZ, et al. Tidsskr Nor Laegeforen. 2007 Mar 1;127(5):579-82. Tidsskr Nor Laegeforen. 2007. PMID: 17332810 Review. Norwegian.
Singh K, Jamshidi N, Zomer R, Piva TJ, Mantri N. Singh K, et al. Int J Mol Sci. 2020 Aug 29;21(17):6265. doi: 10.3390/ijms21176265. Int J Mol Sci. 2020. PMID: 32872551 Free PMC article. Review.
Ganesh S, Cortes-Briones J, Ranganathan M, Radhakrishnan R, Skosnik PD, D’Souza DC. Ganesh S, et al. Int J Neuropsychopharmacol. 2020 Dec 3;23(9):559-570. doi: 10.1093/ijnp/pyaa031. Int J Neuropsychopharmacol. 2020. PMID: 32385508 Free PMC article.
Panlilio LV, Justinova Z. Panlilio LV, et al. Neuropsychopharmacology. 2018 Jan;43(1):116-141. doi: 10.1038/npp.2017.193. Epub 2017 Aug 28. Neuropsychopharmacology. 2018. PMID: 28845848 Free PMC article. Review.
Andre CM, Hausman JF, Guerriero G. Andre CM, et al. Front Plant Sci. 2016 Feb 4;7:19. doi: 10.3389/fpls.2016.00019. eCollection 2016. Front Plant Sci. 2016. PMID: 26870049 Free PMC article. Review.